홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

3,3-Dimethyl-1-(trifluoromethyl)-1,2-benziodoxole → 9-cyclopropyl-2-(4-((trifluoromethoxy)methyl)-1H-imidazol-1-yl)-7,8-dihydro-[1,4]diazepino[7,1-a]isoquinolin-5(4H)-one

HRID 926336
인쇄

반응식

HRID 926336 반응식
[CH:1]1([C:4]2[CH:13]=[CH:12][CH:11]=[C:10]3[C:5]=2[CH2:6][CH2:7][N:8]2[C:18](=[O:19])[CH2:17][N:16]=[C:15]([N:20]4[CH:24]=[C:23]([CH2:25][OH:26])[N:22]=[CH:21]4)[CH:14]=[C:9]23)[CH2:3][CH2:2]1.CC1(C)C2C=CC=CC=2I([C:37]([F:40])([F:39])[F:38])O1>C(Cl)(Cl)Cl.[Zn](N(S(C(F)(F)F)(=O)=O)S(C(F)(F)F)(=O)=O)N(S(C(F)(F)F)(=O)=O)S(C(F)(F)F)(=O)=O>[CH:1]1([C:4]2[CH:13]=[CH:12][CH:11]=[C:10]3[C:5]=2[CH2:6][CH2:7][N:8]2[C:18](=[O:19])[CH2:17][N:16]=[C:15]([N:20]4[CH:24]=[C:23]([CH2:25][O:26][C:37]([F:40])([F:39])[F:38])[N:22]=[CH:21]4)[CH:14]=[C:9]23)[CH2:3][CH2:2]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 2

HCID 160435723,3-Dimethyl-1-(trifluoromethyl)-1,2-benziodoxole2회HCID 867114079-cyclopropyl-2-(4-(hydroxymethyl)-1H-imidazol-1-yl)-7,8-dihydro-[1,4]diazepino[7,1-a]isoquinolin-5(4H)-one

생성물 1

HCID 867114069-cyclopropyl-2-(4-((trifluoromethoxy)methyl)-1H-imidazol-1-yl)-7,8-dihydro-[1,4]diazepino[7,1-a]isoquinolin-5(4H)-one수율 1.9%

시약·촉매·용매 2

HCID 178527593
HCID 178527593, 화합물
촉매
2회
HCID 6212Chloroform용매

실험 절차

A solution of 9-cyclopropyl-2-(4-(hydroxymethyl)-1H-imidazol-1-yl)-7,8-dihydro-[1,4]diazepino[7,1-a]isoquinolin-5(4H)-one (135 mg, 0.38 mmol) in CHCl3 (50 mL) under Ar, was treated with 3,3-Dimethyl-1-(trifluoromethyl)-1,2-benziodoxole (245 mg, 0.78 mmol) and Zn(NTf2)2 (242 mg, 0.39 mmol). The mixture was stirred at RT for 16 h, and then treated again with 3,3-Dimethyl-1-(trifluoromethyl)-1,2-benziodoxole (245 mg, 0.78 mmol) and Zn(NTf2)2 (242 mg, 0.39 mmol). After 24 h, the mixture was poured onto H2O and extracted with DCM. The combined org. layers were then dried over Na2SO4, filtered and concentrated in vacuo. The crude product was purified by flash chromatography (SiO2, DCM/MeOH 100:0 to 95:5) and by SFC (column: PPU 5 m, 250×30 mm, 60 A, Princeton; eluent: isocratic 20% MeOH/CO2 for 11 min; flow 100 mL/min; UV detection at 220 nm) to give the title compound (3 mg). UPLC-MS: MS 417.2 (M+H+); UPLC rt 1.15 min. 1H NMR (400 MHz, DMSO-d6): δ ppm 0.56-0.71 (m, 2H); 0.93-1.05 (m, 2H); 1.91-2.04 (m, 1H); 3.14-3.20 (m, 2H); 3.89-4.01 (m, 2H); 4.34 (br s, 2H); 5.00 (s, 2H); 7.03 (s, 1H); 7.18-7.26 (m, 1H); 7.26-7.34 (m, 1H); 7.69-7.85 (m, 2H); 8.25 (s, 1H).

후처리

  1. waitAfter 24 h
  2. additionthe mixture was poured onto H2O
  3. extractionextracted with DCM
  4. dry with materiallayers were then dried over Na2SO4
  5. filtrationfiltered
  6. concentrationconcentrated in vacuo
  7. customThe crude product was purified by flash chromatography (SiO2, DCM/MeOH 100:0 to 95:5) and by SFC (column: PPU 5 m, 250×30 mm, 60 A, Princeton; eluent: isocratic 20% MeOH/CO2 for 11 min; flow 100 mL/min; UV detection at 220 nm)

출처 및 근거

ORD 기록
ord-3b6248ef0cd147879046a1f5241e9de8
출처 데이터셋
uspto-grants-2016_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09284331B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트